Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress

Fangchinoline attenuates hepatic fibrosis by regulating taurine metabolism and oxidative stress

BackgroundHepatic fibrosis emerges as a pathological hallmark in the pathogenesis of chronic hepatopathies. Stephania tetrandra S. Moore is a traditional Chinese herb used to treat liver disease. However, the anti-hepatic fibrosis effect of fangchinoline (FAN), an active ingredient of S. tetrandra S...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hui Yin, Hang Lian, Yawen Wang, Luoting Chen, Xueting Liu, Yange Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Pharmacology
Subjects:	fangchinoline hepatic fibrosis taurine oxidative stress hepatic stellate cells
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1633519/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Inhibiting CXCR6 promotes senescence of activated hepatic stellate cells with limited proinflammatory SASP to attenuate hepatic fibrosis
by: Sheng Liqin, et al.
Published: (2025-08-01)

Effect of T lymphocyte on hepatic stellate cell activation in liver fibrosis
by: GONG Xiaoqian, et al.
Published: (2025-04-01)

Tanshinone IIA attenuates hepatic stellate cell activation, oxidative stress, and liver fibrosis by inhibiting YAP signaling
by: Dan Wang, et al.
Published: (2025-06-01)

Therapeutic Potential of PDA@CeO2 in Suppressing Hepatic Stellate Cell Activation and Preventing Liver Fibrosis
by: Li HM, et al.
Published: (2025-07-01)

Notoginsenoside R2 attenuates hepatic fibrosis via STAT3-dependent hepatic stellate cells senescence induction and inflammatory microenvironment suppression
by: Kaili Deng, et al.
Published: (2025-09-01)

Hepatic stellate cell-specific miR-214 expression alleviates liver fibrosis without boosting steatosis and inflammation
by: Fangqing Zhao, et al.
Published: (2025-07-01)

Dynamic crosstalk between HSCs and liver microenvironment: multicellular interactions in the regulation of liver fibrosis
by: Luping Wang, et al.
Published: (2025-07-01)

Furin inhibits HSCs activation and ameliorates liver fibrosis by regulating PTEN‐L/PINK1/parkin mediated mitophagy in mouse
by: Yan‐Wei Song, et al.
Published: (2025-05-01)

Fusion protein of retinol‐binding protein and albumin domain III reduces liver fibrosis
by: Hongsik Lee, et al.
Published: (2015-04-01)

Chondroitin Sulfate-Based Imatinib Nanoparticles Targeting Activated Hepatic Stellate Cells Against Hepatic Fibrosis
by: Xunzhi Liu, et al.
Published: (2025-03-01)

Toll-like receptor 4-mediated inflammatory stimulation in Kupffer cell enhances arsenite-induced liver fibrosis by triggering hepatic stellate cell activation
by: Qian Song, et al.
Published: (2025-09-01)

Autocrine GDF10 Inhibits Hepatic Stellate Cell Activation via BMPR2/ALK3 Receptor to Prevent Liver Fibrosis
by: Yinliang Zhang, et al.
Published: (2025-05-01)

Elevated miR-34a induced by lipotoxicity and inflammation mediates pathophysiological communication between hepatocytes and hepatic stellate cells in liver fibrosis
by: Qihua Duan, et al.
Published: (2025-11-01)

Liraglutide inhibits the proliferation of rat hepatic stellate cells under high glucose conditions by suppressing the ERK signaling pathway
by: Bingge Fan, et al.
Published: (2025-04-01)

SOX9 predicts progression toward cirrhosis in patients while its loss protects against liver fibrosis
by: Varinder S Athwal, et al.
Published: (2017-11-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

Senkyunolide I suppresses hepatic stellate cell activation and liver fibrosis by reprogramming VDR-dependent fatty acid metabolism
by: Mengyao Zhu, et al.
Published: (2025-06-01)

Investigation of the inhibitory effects of total flavonoids of litchi seed on Clonorchis sinensis-induced liver damage and fibrosis
by: Liuchun Luo, et al.
Published: (2025-07-01)

The Non‐Canonical ChREBPα Activity Suppresses the Activation of Hepatic Stellate Cells and Liver Fibrosis by Antagonizing TGF‐β‐E2F1 Axis
by: Jian Zhang, et al.
Published: (2025-08-01)

Circulating let‐7 Predicts Hepatic Fibrogenesis of 12‐Month Post‐Nucleos(t)ide Analog Treatment in Patients With Hepatitis B Virus
by: Yi‐Shan Tsai, et al.
Published: (2025-06-01)

Pathohistological and immunohistochemical features of chronic viral hepatitis b progression
by: M. A. Shishkin
Published: (2015-04-01)

Relationship of tea consumption with hepatic steatosis and fibrosis: findings from a longitudinal RaNCD cohort
by: Shaimaa A. Qaisar, et al.
Published: (2025-03-01)

Nitric oxide donor S‐Nitroso‐N‐acetyl penicillamine for hepatic stellate cells to restore quiescence
by: Junbao Du, et al.
Published: (2024-12-01)

TGF-β inhibitors: the future for prevention and treatment of liver fibrosis?
by: Weili Wang, et al.
Published: (2025-06-01)

Prognostic model of rapid hepatic fibrosis progression in men with chronic hepatitis C
by: T. I. Koval, et al.
Published: (2019-05-01)

Pathomorphology of liver fibrosis in trepanobioptates of patients with steatohepatitis: main types, sources of development, features of progression
by: V. A. Tumanskiy, et al.
Published: (2017-12-01)

Morphological and ultrasound features of liver fibrosis in children with autoimmune hepatitis
by: V. S. Berezenko, et al.
Published: (2018-12-01)

MicroRNAs in Liver Fibrosis: Unraveling Intercellular Crosstalk and the Regulatory Functions of MicroRNA-223
by: Chinnatam Phetkong, et al.
Published: (2025-06-01)

Multi-omics analysis of host-microbiome interactions in a mouse model of congenital hepatic fibrosis
by: Mengfan Jiao, et al.
Published: (2025-03-01)

A study to assess hepatic steatosis and fibrosis in chronic hepatitis B patients with the help of non-invasive tests
by: Gaurav Singh, et al.
Published: (2025-07-01)

MRI findings of confluent hepatic fibrosis caused by different etiologies
by: Dan Yu, et al.
Published: (2025-07-01)

Tanshinone IIA alleviates liver fibrosis by suppressing hepatic stellate cell proliferation via ERK/cyclin D1/p-Smad3L signaling axis
by: Wenjing Liao, et al.
Published: (2025-05-01)

THE EFFECT OF TAURINE ON REPRODUCTIVE EFFICIENCY IN MALE RATS FED HIGH CHOLESTEROL DIET
by: Nameer A.Kareem Alzubaidi Mohammed Ali Al Diwan
Published: (2013-06-01)

Association of alpha-1 acid glycoprotein with hepatic steatosis and liver fibrosis among women: a population-based study
by: Sichang Wang
Published: (2025-08-01)

Are bone morphogenetic protein-7 (BMP-7) serum levels correlated with development of hepatic fibrosis?
by: Nazlim Aktug Demir, et al.
Published: (2014-05-01)

The diagnostic value of indirect markers of liver fibrosis in patients with chronic hepatitis B
by: D. V. Tereshkov, et al.
Published: (2020-03-01)

Patients with chronic hepatitis B exhibiting significant inflammation and fibrosis should pay particular attention to the status of hepatic steatosis during antiviral therapy
by: Bingqing Yang, et al.
Published: (2025-05-01)

The Associations of Serum Folate Forms with Metabolic Dysfunction-Associated Fatty Liver Disease and Liver Fibrosis: A Nationwide Cross-Sectional Study
by: Hai Zhao, et al.
Published: (2025-06-01)

A Life-threatening Adverse Effect of Taurine-containing Energy Drink: Thrombocytopenia
by: Erhan Özyurt, et al.
Published: (2024-03-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)